P. Schaefer Price
Director/Board Member at Arbutus Biopharma, Inc.
Profile
P.
Schaefer Price is currently a Director at Arbutus Biopharma, Inc. Prior to this, he was the President, Chief Executive Officer & Director at Pharmasset, Inc. from 2011 to 2012.
He was also the Managing Director at Lakeshore Bioventures from 2001 to 2002.
Earlier in his career, he served as Vice President at Burrill & Craves and as President at PowderJect Vaccines, Inc. from 1997 to 2001.
Mr. Price received his undergraduate degree from the University of Wisconsin and his MBA from the University of Minnesota.
P. Schaefer Price active positions
| Companies | Position | Start |
|---|---|---|
Arbutus Biopharma, Inc.
 Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA. | Director/Board Member | 31/07/2014 |
Former positions of P. Schaefer Price
| Companies | Position | End |
|---|---|---|
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | President | 11/01/2012 |
| Lakeshore Bioventures | Corporate Officer/Principal | 31/08/2002 |
| PowderJect Vaccines, Inc. | President | 30/06/2001 |
| Burrill & Craves | Corporate Officer/Principal | - |
Training of P. Schaefer Price
| University of Wisconsin | Undergraduate Degree |
| University of Minnesota | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Health Technology |
Arbutus Biopharma, Inc.
Arbutus Biopharma, Inc. BiotechnologyHealth Technology Arbutus Biopharma, Inc. engages in the research and development of pharmaceutical products for Hepatitis B. Its operation includes covalently closed circular DNA, Capsid Assembly, Cyclophilins, and Surface Antigen. The company was founded by Patrick T. Higgins, Michael J. Sofia, Michael J. McElhaugh, and Bryce A. Roberts in May 2012 and is headquartered in Doylestown, PA. | Health Technology |
| Burrill & Craves | |
| PowderJect Vaccines, Inc. | |
| Lakeshore Bioventures |
- Stock Market
- Insiders
- P. Schaefer Price
